KEVIN C TANG Insider Trading $HRTX HERON THERAPEUTICS, INC. /DE/
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN C TANG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN C TANG. KEVIN C TANG is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and Director in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and 10% Owner in Aptevo Therapeutics Inc. ($APVO) and Chief Executive Officer in Odonate Therapeutics, Inc. ($ODT).
KEVIN C TANG in HERON THERAPEUTICS, INC. /DE/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN C TANG: Director
Holdings: 5,799,810 shares
Latest Transaction: Dec 23 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN C TANG in HERON THERAPEUTICS, INC. /DE/
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APVO, CYCC, HRTX, LJPC, ODT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23 2019 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 25.02 | 17,000 | 425,340 | 17,000 | |
| Oct 07 2019 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 17.50 | 285,714 | 4,999,995 | 5,799,810 | 5.5 M to 5.8 M (+5.18 %) |
| Dec 18 2018 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 24.97 | 17,000 | 424,490 | 17,000 | |
| Sep 12 2018 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Sell | S | 35.75 | 2,695,000 | 96,346,250 | 5,830,215 | 8.5 M to 5.8 M (-31.61 %) |
| Apr 02 2018 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 26.00 | 192,308 | 5,000,008 | 8,525,215 | 8.3 M to 8.5 M (+2.31 %) |
| Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 17.00 | 17,000 | 289,000 | 17,000 | |
| Jan 23 2017 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 12.20 | 2,459,016 | 29,999,995 | 8,332,907 | 5.9 M to 8.3 M (+41.86 %) |
| Dec 23 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 13.00 | 17,000 | 221,000 | 17,000 | |
| Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | M | 3.60 | 1,250,000 | 4,500,000 | 0 | |
| Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Payment of Exercise | F | 18.47 | 243,639 | 4,500,012 | 5,873,891 | 6.1 M to 5.9 M (-3.98 %) |
| Jun 20 2016 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | M | 3.60 | 1,250,000 | 4,500,000 | 6,117,530 | 4.9 M to 6.1 M (+25.68 %) |
| Dec 24 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Option Exercise | A | 29.41 | 17,000 | 499,970 | 17,000 | |
| Jun 12 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 24.75 | 121,212 | 2,999,997 | 4,867,530 | 4.7 M to 4.9 M (+2.55 %) |
| Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 23.84 | 32,395 | 772,294 | 4,746,318 | 4.7 M to 4.7 M (+0.69 %) |
| Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 19.30 | 2,380 | 45,934 | 4,713,923 | 4.7 M to 4.7 M (+0.05 %) |
| Jun 02 2015 | HRTX | HERON THERAPEUTICS ... | TANG KEVIN C | Director | Buy | P | 19.74 | 115,225 | 2,274,058 | 4,711,543 | 4.6 M to 4.7 M (+2.51 %) |
Page: 1